<code id='AFA47407F7'></code><style id='AFA47407F7'></style>
    • <acronym id='AFA47407F7'></acronym>
      <center id='AFA47407F7'><center id='AFA47407F7'><tfoot id='AFA47407F7'></tfoot></center><abbr id='AFA47407F7'><dir id='AFA47407F7'><tfoot id='AFA47407F7'></tfoot><noframes id='AFA47407F7'>

    • <optgroup id='AFA47407F7'><strike id='AFA47407F7'><sup id='AFA47407F7'></sup></strike><code id='AFA47407F7'></code></optgroup>
        1. <b id='AFA47407F7'><label id='AFA47407F7'><select id='AFA47407F7'><dt id='AFA47407F7'><span id='AFA47407F7'></span></dt></select></label></b><u id='AFA47407F7'></u>
          <i id='AFA47407F7'><strike id='AFA47407F7'><tt id='AFA47407F7'><pre id='AFA47407F7'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:44565
          Boxes of Wegovy — pharma coverage from STAT
          Carsten Snejbjerg/Bloomberg

          LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs. 

          Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. In turn, Novo Nordisk is buying three of Catalent’s fill-finish sites from the investment group for $11 billion. Novo Holdings manages the assets of the Novo Nordisk Foundation, which has a controlling stake in the pharmaceutical company.

          advertisement

          Catalent has been involved in the production of Novo’s obesity treatment Wegovy. With the agreement, Novo will pick up sites that focus on filling drugs in Italy, Brussels, and Bloomington, Ind. All have already been doing work for Novo. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness
          Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

          17:55UkrainianPresidentVolodymyrZelenskyyspeakswithABCNews'MarthaRaddatz.YuriyBoyko/ABCNewsKYIV,Ukra

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

          1:10PresidentJoeBidenparticipatesinaceremonialarrivalandinspectionofthehonorguardwithBritain'sKingCh